Proceedings of the National Academy of Sciences · 2018 · 76 citations · 35 references
Life SciencesMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DiscoveryHost-pathogen InteractionsAntibacterial PharmacologyAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial Virulence FactorsMicrobial Virulence FactorsAntibiotic DiscoveryBacterial Chemical GeneticsMethicillin-resistant Staphylococcus Aureus TreatmentMultidrug-resistant OrganismsMultidrug-resistant PathogensNovel Antibacterial AgentsPathogen-host Interaction TargetingResistance Mechanisms In Staphylococci
Significance The dissemination of antibiotic resistance in pathogenic bacteria is remarkable, and antivirulence agents with novel mechanisms of action could lead to innovative therapeutic concepts. The simultaneous suppression of multiple virulence factors or pathways using small-molecule compounds is an attractive approach to reducing the virulence of Staphylococcus aureus and may offer promising therapeutic potential in combating multidrug-resistant bacteria such as methicillin-resistant S. aureus . Here we describe a conceptual breakthrough in applying chemical genetics to probe for small-molecule compounds that will suppress the expression of multiple virulence factors in S. aureus simultaneously. Compound M21 has the ability to reverse virulent S. aureus to a nonvirulent state, as demonstrated in a mouse model of infection.
35
A Cholesterol Biosynthesis Inhibitor Blocks <i>Staphylococcus aureus</i> Virulence
Chia-I Liu, George Y. Liu, Yongcheng Song et al. · Science · 2008 · 495 citations · Full text
Stijn Blot, Koenraad Vandewoude, Eric A. J. Hoste et al. · Archives of Internal Medicine · 2002 · 468 citations
Dennis L. Stevens, Yongsheng Ma, Daniel B. Salmi et al. · The Journal of Infectious Diseases · 2006 · 449 citations